List of Biosimilars Companies in Switzerland - 5

ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.

BioXpress Therapeutics SA is a premier provider of high-quality biologic APIs for unmet need indications, such as cancer, inflammation and autoimmunity.

Looking for a trusted partner in the development of cell lines and manufacturing processes? Look no further. With over 20 years of experience, we specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus). We have a proven track record of expressing all types of proteins, including bi-specific mAb, Fc-fusions, viral proteins, cytokines, and more. Our team of scientists is ready to support your project from start to finish, including process development, analytical methods, scale-up, tox-batches, and Master Cell Banking. At our company, we pride ourselves on our commitment to quality and customer satisfaction. Contact us today to see how we can help you achieve your goals and be your trusted partner in cell line and process development.

iQone Healthcare Switzerland is an independent Swiss specialty pharma company focussing on the commercialisation of biosimilars, orphan drugs and oncology products. As a Swiss company founded by leading members of the pharmaceutical industry, we have created an agile model to accelerate the transition to biosimilars. Today, the choice of biosimilars is tangible proof of physicians' commitment to the public interest. And prescribing the best available treatment at the best price is an issue of social responsibility. Be the actor of this paradigm shift together with us!

Sandoz is the global leader in generic and biosimilar medicines. ​ ​Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance.​ We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars.